✦ LIBER ✦

PP55 A MAGE-A3 specific quantitative RT-PCR assay used for patient accrual in MAGRIT, a Phase III ASCI (Antigen-Specific Cancer Immunotherapeutic) trial in adjuvant NSCLC

✍ Scribed by T. Coche; J. Louahed; O. Gruselle; H. Wu; H. Hoffmann; E. Esteban-Gonzales; P. Therasse

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9021 Preliminary results of MAGE-A3 expr

✍ Zielinski, M.; Laskowski, U.; Bieselt, R.; Reck, M.; Strausz, J.; Perdeus, J.; P 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

MAGE-A3 Antigen-Specific Cancer Immunoth

✍ Eisen, T.; Vansteenkiste, J.; Zielinski, M.; Linder, A.; Dahabreh, J.; Jassem, J 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

102PD MAGE-A3 ANTIGEN-SPECIFIC CANCER IM

✍ Passlick, B.; Vansteenkiste, J.; Zielinski, M.; Linder, A.; Dahabreh, J.; Esteba 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 44 KB

72PD LOBECTOMY IN COMBINATION WITH RADIC

✍ Zielinski, M.; Zo, J.; Vanakesa, T.; Dahabreh, J.; Hoffmann, H.; Holzer, M.; Mit 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 90 KB